A Phase I/II study of a Ganoderma lucidum extract in patients with chronic hepatitis B Shufeng Zhou1, Yihuai Gao2, Guoliang Chen3, Xihu Dai4, and Jingxian Ye5 1Division of Pharmacology and Clinical Pharmacology, Faculty of Medicine and Health Science, the University of